We are live on
!
Find out more
YU
Yale University Portfolio holdings
AUM
$2.05M
1-Year Est. Return
1.81%
This Fund
S&P 500
This Quarter
Est. Return
-16.51%
1 Year Est. Return
+1.81%
3 Year Est. Return
+33.71%
5 Year Est. Return
-16.42%
10 Year Est. Return
+71.27%
AUM
$324M
AUM Growth
-$28.4M
(-8.1%)
Cap. Flow
-$46.7M
Cap. Flow
% of AUM
-14.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
7
Increased
–
Reduced
1
Closed
5
Avg Time Held
1.1
quarters
Top 10 Avg Time Held
1.1
quarters
Top 20 Avg Time Held
1.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$223M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$73.7M |
| 3 |
ESMC
Escalon Medical Corp
ESMC
|
+$3.51M |
| 4 |
Atara Biotherapeutics
ATRA
|
+$451K |
| 5 |
IIN
IntriCon Corporation
IIN
|
+$234K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$147M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$133M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$57.7M |
| 4 |
Happen Inc
HAPN
|
+$6.41M |
| 5 |
Antero Resources
AR
|
+$3.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.82% |
| 2 | Miscellaneous | 33.6% |
| 3 | Healthcare | 29.78% |
| 4 | Technology | 1.8% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
JPMorgan Chase
JPM
$885B
| $113M | 34.82% |
+3,410,000
| New | +$223M |
2015 Q3
0 quarters
|
|
|
2
iShares China Large-Cap ETF
FXI
$3.95B
| $109M | 33.52% |
+1,895,400
| New | +$73.7M |
2015 Q3
0 quarters
|
|
|
ESMC
3
DELISTED
Escalon Medical Corp
ESMC
| $95.9M | 29.59% |
+2,703,700
| New | +$3.51M |
2015 Q3
0 quarters
|
|
|
IIN
4
DELISTED
IntriCon Corporation
IIN
| $5.83M | 1.8% |
+33,927
| New | +$234K |
2015 Q3
0 quarters
|
|
|
5
Atara Biotherapeutics
ATRA
$95.2M
| $291K | 0.09% |
+370
| New | +$451K |
2015 Q3
0 quarters
|
|
6
Ironwood Pharmaceuticals
IRWD
$631M
| $250K | 0.08% |
+7,448
| New | +$69.5K |
2015 Q3
0 quarters
|
|
|
7
iShares MSCI EAFE ETF
EFA
$76.4B
| $244K | 0.08% |
4,000
-2,385,400
| -100% | -$147M |
2013 Q2
9 quarters
|
|
8
Corcept Therapeutics
CORT
$13.1B
| $84K | 0.03% |
+22,334
| New | +$113K |
2015 Q3
0 quarters
|
|
|
9
Antero Resources
AR
$11B
| – | – |
-90,000
| Closed | -$3.09M | – |
|
10
Inogen
INGN
$164M
| – | – |
-8,892
| Closed | -$396K | – |
|
|
11
Happen Inc
HAPN
$1.75B
| – | – |
-86,913
| Closed | -$6.41M | – |
|
|
12
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| – | – |
-3,258,000
| Closed | -$133M | – |
|
|
ALXN
13
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-319,273
| Closed | -$57.7M | – |
|
Similar funds
SGIHM
LFA
IVMX
CG
JBFJ
CLIC
GFWEX
S3G1
Yale University's Q3 2015 Portfolio in Review
As of Q3 2015, Yale University held 13 positions worth $324M, down 8.1% from $353M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Yale University withdrew a net $46.7M in Q3 2015, closing 5 positions and reducing 1 holding. Its most notable exit was Vanguard FTSE Emerging Markets ETF, an estimated $133M position sold in full.
By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 1.8% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, Yale University opened a new position in JPMorgan Chase worth $113M.
- Yale University's largest Q3 2015 buy was JPMorgan Chase: 3,410,000 shares worth $113M.
- Yale University's biggest Q3 2015 reduction was iShares MSCI EAFE ETF, cutting an estimated $147M.
- Yale University fully exited Vanguard FTSE Emerging Markets ETF in Q3 2015, selling an estimated $133M.
- Yale University's ten largest holdings make up 100% of its $324M portfolio in Q3 2015.
- Yale University opened 7 new positions and closed 5 in Q3 2015.
- Yale University's portfolio value fell 8.1% quarter-over-quarter to $324M.
Based on Yale University's 13F filing for Q3 2015, filed 13 Nov 2015.